Tenaya Therapeutics Inc — Cash Flow (NASDAQ:TNYA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -60.81 M-104.42 M-102.07 M-90.5 M-68.26 M -68.26 M Cash from investing activities -238.56 M83.65 M48.72 M1.13 M56.08 M 56.08 M Cash from financing activities 208.97 M77.77 M4.05 M47.75 M108.41 M 108.41 M Free cash flow -85.93 M-125.05 M-103.31 M-91.53 M-68.88 M -68.88 M

Haberler

Leerink Partners, Tenaya hissesi için 2 dolar hedefle tavsiyesini yineledi

William Blair, Tenaya Therapeutics hissesi için Outperform tavsiyesini korudu

Leerink Partners reiterates Outperform on Tenaya stock at $2

William Blair reiterates Outperform on Tenaya Therapeutics stock

3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts - TipRanks.com

Tenaya’nın HDAC6 inhibitörü DMD kas çalışmalarında umut veriyor

Tenaya’s HDAC6 inhibitor shows promise in DMD muscle studies

Tenaya ve Alnylam kalp hastalığı gen hedefleri için ortaklık kurdu

Tenaya Therapeutics Stock Jumps After New Alnylam Deal - Alnylam Pharmaceuticals (NASDAQ:ALNY), Tenaya Therapeutics (NASDAQ:TNYA)

Tenaya Therapeutics receives Nasdaq notice on minimum bid price and amends equity plan

Canaccord, Tenaya Therapeutics için hedef fiyatı 5 dolara düşürdü

Tenaya Therapeutics stock price target lowered to $5 at Canaccord